What is Krystal Biotech, Inc.'s free cash flow?

Krystal Biotech, Inc. (KRYS) reported free cash flow of $73.23M in Q1 2026.

How has Krystal Biotech, Inc.'s free cash flow changed year-over-year?

Krystal Biotech, Inc.'s free cash flow increased by 195.7% year-over-year, from $24.77M to $73.23M.

What is the long-term trend for Krystal Biotech, Inc.'s free cash flow?

Over 4 years (2021 to 2025), Krystal Biotech, Inc.'s free cash flow has grown at a 12.9% compound annual growth rate (CAGR), from -$116.27M to $188.91M.

Krystal Biotech, Inc. KRYS Free cash flow

Free cash flow at other companies

Gilead SciencesGILD

$2.43B+46.8%

AbbVieABBV

$3.56B+155%

BridgeBio PharmaBBIO

——

RevvityRVTY

——

IncyteINCY

——

Roivant SciencesROIV

——

Other financials

Income statement

See full

Revenue$116.4M+31.9%

Operating income$53.7M+48.1%

Net income$55.9M+56.5%

EPS (diluted)$1.83+52.5%

Balance sheet

See full

Cash & equivalents$501.3M+62.4%

Total debt$9.1M-5.7%

Total equity$1.3B+29.7%

Total assets$1.4B+30.0%

Cash flow

See full

Operating cash flow$80.4M+160%

CapEx$7.1M+15.2%

Valuation

See full

Market cap$10.26B+45.4%

Enterprise value$9.77B+44.2%

P/E45.6×-11.3×

P/S24.6×+3.4×

Profitability

See full

Operating margin42.8%+10.2pp

Net margin53.9%+16.7pp

FCF margin56.9%+16.5pp

Returns & leverage

See full

Return on equity19.9%+6.0pp

Debt / equity0×0.0×

Current ratio9.5×-0.2×

Where this comes from

Calculated from Krystal Biotech, Inc.’s reported figures.

$80.4Mnet cash from operating−$7.1Mcapital expenditures=$73.23M

The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Krystal Biotech, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Krystal Biotech, Inc.'s free cash flow?: Krystal Biotech, Inc. (KRYS) reported free cash flow of $73.23M in Q1 2026.
How has Krystal Biotech, Inc.'s free cash flow changed year-over-year?: Krystal Biotech, Inc.'s free cash flow increased by 195.7% year-over-year, from $24.77M to $73.23M.
What is the long-term trend for Krystal Biotech, Inc.'s free cash flow?: Over 4 years (2021 to 2025), Krystal Biotech, Inc.'s free cash flow has grown at a 12.9% compound annual growth rate (CAGR), from -$116.27M to $188.91M.